Trials / Completed
CompletedNCT07317648
ClearSight NextGen1 Study
ClearSight NextGen System Clinical Development Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Edwards Lifesciences · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, non-randomized single arm study using the investigational ClearSight NextGen (CSNG) system in adult subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ClearSight NextGen system | Study devices will be applied to subjects for monitoring for the duration of the procedure. |
Timeline
- Start date
- 2025-10-16
- Primary completion
- 2026-03-05
- Completion
- 2026-03-05
- First posted
- 2026-01-05
- Last updated
- 2026-04-08
Locations
1 site across 1 country: United Kingdom
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07317648. Inclusion in this directory is not an endorsement.